Aspen Pharmacare Holdings Ltd 2024 IR

The report outlines Aspen's strategic and financial performance for the fiscal year ended June 30, 2024, highlighting a 10% increase in revenue to R44.7 billion. The company successfully expanded its emerging market footprint through key acquisitions from Viatris in Latin America and Sandoz in China, while also securing a commercial license for GLP-1 products. Additionally, Aspen made significant progress on its sterile manufacturing capacity-fill strategy, including agreements with Novo Nordisk and Serum Institute. On the environmental front, the company reduced its overall carbon emissions by 28.4% over five years, with renewable electricity consumption rising to 18%.

Company: Aspen Pharmacare Holdings Ltd

Sector: Health Care

Country: South Africa

Year: 2024

Type: IR

Pages: 144

Back to company

Aspen Pharmacare Holdings Ltd

Aspen Pharmacare Holdings Ltd 2024 Integrated Report

Integrated Report

The report outlines Aspen's strategic and financial performance for the fiscal year ended June 30, 2024, highlighting a 10% increase in revenue to R44.7 billion. The company successfully expanded its emerging market footprint through key acquisitions from Viatris in Latin America and Sandoz in China, while also securing a commercial license for GLP-1 products. Additionally, Aspen made significant progress on its sterile manufacturing capacity-fill strategy, including agreements with Novo Nordisk and Serum Institute. On the environmental front, the company reduced its overall carbon emissions by 28.4% over five years, with renewable electricity consumption rising to 18%.

Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.

Document Details

Report Year

2024

Reporting Period

Jul 1, 2023 - Jun 30, 2024

Fiscal Year

2024

Type

Integrated Report

Language

English

Pages

 

File Size

 

Standards & Assurance

Reporting Standards

Materiality Assessment

Assurance

Assurance Provider

Assurance Standard

ESG Data?Experimental — AI-extracted data, may contain inaccuracies

Emissions

Scope 1:

Scope 2:

Energy Consumption

Renewable Energy

Water Consumption

Total Waste

Women on Board

Women in Management

Workplace Fatalities

Net Zero Target

Employees

Aspen Pharmacare Holdings Ltd 2024 Integrated Report - Free PDF